Abstract
Bloodstream infections remain an important cause of morbidity/mortality worldwide. The diagnosis of these infections is time-consuming, even with the use of automated blood culture systems. Several systems based on molecular biology and, more recently, proteomics have been developed to allow rapid and accurate diagnosis of bloodstream infections. Here, we describe some recently technologies and commercial systems available to detect and to identify microorganisms and bacterial antimicrobial resistance-coding genes from positive blood culture bottles and whole-blood samples. Evaluation of clinical outcomes in multicenter studies and clinical trials with these new tests is warranted in conjunction with antimicrobial stewardship use and programs for interpretation of results to be provided to physicians.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
